Euro-Med Laboratories Phil., Inc. (PSE:EURO)
Philippines · Delayed Price · Currency is PHP 1.030
+0.010 (0.98%)
At close: Feb 9, 2026
PSE:EURO Cash Flow Statement
Financials in millions PHP. Fiscal year is January - December.
Millions PHP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 393.83 | 337.68 | 289.95 | 199.89 | 169.05 | 210.05 |
Depreciation & Amortization | 414.81 | 329.59 | 298.23 | 286.89 | 278.33 | 265.87 |
Loss (Gain) From Sale of Assets | -36.45 | -36.45 | - | - | - | - |
Loss (Gain) From Sale of Investments | -22.47 | -22.47 | -13.23 | 1.09 | -43.93 | -3.65 |
Provision & Write-off of Bad Debts | 16.86 | 16.86 | 3.69 | 4.25 | 13.17 | 14.74 |
Other Operating Activities | -32.51 | -17.23 | 27.23 | 19.61 | 14.88 | -3.61 |
Change in Accounts Receivable | -234.49 | -316.16 | -187.32 | -64.71 | 211.04 | 183.71 |
Change in Inventory | 7.02 | -48.89 | -156.16 | -272.43 | 132.05 | -231.07 |
Change in Accounts Payable | 29.81 | -94.29 | 167.63 | 28.74 | -353.51 | 70.99 |
Change in Other Net Operating Assets | -48.09 | 98.17 | -75.9 | -55.09 | 67.33 | -66.17 |
Operating Cash Flow | 488.32 | 246.81 | 354.13 | 148.23 | 488.4 | 440.87 |
Operating Cash Flow Growth | -8.09% | -30.30% | 138.90% | -69.65% | 10.78% | -32.80% |
Capital Expenditures | -241.31 | -196.08 | -291.87 | -88.89 | -285.57 | -450.77 |
Sale of Property, Plant & Equipment | 43.14 | 43.14 | - | - | - | - |
Investment in Securities | - | - | - | - | 72.85 | 15.24 |
Investing Cash Flow | -198.17 | -152.94 | -291.87 | -88.89 | -212.72 | -435.53 |
Short-Term Debt Issued | - | 3,135 | 3,478 | 2,399 | 1,884 | 2,135 |
Long-Term Debt Issued | - | 209.79 | 309.7 | 64 | 598.8 | 196.11 |
Total Debt Issued | 3,220 | 3,345 | 3,788 | 2,463 | 2,483 | 2,331 |
Short-Term Debt Repaid | - | -3,109 | -3,097 | -2,049 | -2,243 | -1,789 |
Long-Term Debt Repaid | - | -107.37 | -349.5 | -271.96 | -475 | -914.7 |
Total Debt Repaid | -3,480 | -3,216 | -3,447 | -2,321 | -2,718 | -2,704 |
Net Debt Issued (Repaid) | -260.57 | 128.62 | 341.32 | 142.36 | -235.68 | -372.77 |
Common Dividends Paid | -246.73 | -246.73 | -143.92 | -143.92 | - | -205.61 |
Financing Cash Flow | -507.3 | -118.11 | 197.39 | -1.56 | -235.68 | -578.38 |
Foreign Exchange Rate Adjustments | 0.51 | 0.51 | 5.98 | 3.43 | 6.08 | -14.24 |
Net Cash Flow | -48.64 | -23.73 | 265.63 | 61.21 | 46.09 | -587.27 |
Free Cash Flow | 247.01 | 50.73 | 62.26 | 59.35 | 202.83 | -9.9 |
Free Cash Flow Growth | 24.98% | -18.52% | 4.91% | -70.74% | - | - |
Free Cash Flow Margin | 3.68% | 0.88% | 1.18% | 1.41% | 5.65% | -0.26% |
Free Cash Flow Per Share | 0.06 | 0.01 | 0.01 | 0.01 | 0.05 | -0.00 |
Cash Interest Paid | 296.78 | 295.57 | 261 | 196.45 | 206.8 | 202.94 |
Cash Income Tax Paid | 177.9 | 140.38 | 95.04 | 68.89 | 86.43 | 160.21 |
Levered Free Cash Flow | 325.85 | 65.15 | 2.47 | -57.12 | 123.61 | -80.75 |
Unlevered Free Cash Flow | 519.86 | 257.52 | 171.5 | 72.13 | 256.85 | 53.85 |
Change in Working Capital | -245.75 | -361.17 | -251.74 | -363.5 | 56.91 | -42.53 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.